Response to Professor Rumboldt’s reaction to our letter on hydroxyethyl starch use in managing aluminium phosphide poisoning

1. Marashi SM, Nasri-Nasrabadi Z. Can sodium bicarbonate really help in treating metabolic acidosis caused by aluminium phosphide poisoning? Arh Hig Rada Toksikol 2015;66:83-4. doi: 10.1515/aiht-2015-66-263710.1515/aiht-2015-66-2637Search in Google Scholar

2. Siwach SB, Jagdish K, Katyal VK, Dhall A, Bhardwaj G. Prognostic indices in aluminium phosphide poisoning: Observations on acidosis and central venous pressure. J Assoc Physicians India 1997;45:693-5.Search in Google Scholar

3. Siddaiah LM, Adhyapak SM, Jaydev SM, Shetty GG, Varghese K, Patil CB, Iyengar SS. Intra-aortic balloon pump in toxic myocarditis due to aluminum phosphide poisoning. J Med Toxicol 2009;5:80-3. doi: 10.1007/BF0316109310.1007/BF03161093Search in Google Scholar

4. Agrawal VK, Bansal A, Singh RK, Kumawat BL, Mahajan P. Aluminium phopsphide poisoning: possible role of supportive measures in the absence of specific antidote. Indian J Crit Care Med 2015;19:109-12. doi: 10.4103/0972-5229.15101910.4103/0972-5229.151019Search in Google Scholar

5. Chefurka W, Kashi KP, Bond EJ. The effect of phosphine on electron transport in mitochondria. Pestic Biochem Physiol 1976;6:65-84. doi:10.1016/0048-3575(76)90010-910.1016/0048-3575(76)90010-9Search in Google Scholar

6. Jaiswal S, Verma RK, Tewari N. Aluminum phosphide poisoning: Effect of correction of severe metabolic acidosis on patient outcome. Indian J Crit Care Med 2009;13:21-4. doi: 10.4103/0972-5229.5311110.4103/0972-5229.53111277226219881175Search in Google Scholar

7. Soltaninejad K, Nelson LS, Bahreini SA, Shadnia S. Fatal aluminum phosphide poisoning in Tehran-Iran from 2007 to 2010. Indian J Med Sci 2012;66:66-70. doi: 10.4103/0019-5359.11090910.4103/0019-5359.110909Search in Google Scholar

8. Shadnia S, Mehrpour O, Soltaninejad K. A simplified acute physiology score in the prediction of acute aluminum phosphide poisoning outcome. Indian J Med Sci 2010;64:532-9. doi: 10.4103/0019-5359.7592810.4103/0019-5359.75928Search in Google Scholar

9. Jain AK, Nigam M, Garg SD, Dubey BP, Arora A. Aluminium phosphide poisoning autopsy findings. J Indian Acad Forensic Med (JIAFM) 2005;27:35-9.Search in Google Scholar

10. Mehrpour O, Dolati M, Soltaninejad K, Shadnia S, Nazparvar B. Evaluation of histopathological changes in fatal aluminum phosphid e poisoning. Indian J Forensic Med Toxicol 2008;2:34-6 [displayed 4 March 2015]. Available from: http://www.indmedica.com/journals.php?journalid=11&issueid=131&articleid=1739&action=articleSearch in Google Scholar

11. Marashi SM, Arefi M, Behnoush B, Nasrabad MG, Nasri Nasrabadi Z. Could hydroxyethyl starch be a therapeutic option in management of acute aluminum phosphide toxicity? Med Hypotheses 2011;76:596-8. doi: 10.1016/j. mehy.2011.01.009Search in Google Scholar

12. Marashi SM, Majidi M, Raji Asadabadi H, Nasri Nasrabadi Z. A common misconception in the management of aluminium phosphide poisoning. Arh Hig Rada Toksikol 2013;64:475-6. doi: 10.2478/10004-1254-64-2013-240410.2478/10004-1254-64-2013-240424084356Search in Google Scholar

13. Nasri Nasrabadi Z, Marashi SM. Comments on “A systematic review of aluminium phosphide poisoning”. Arh Hig Rada Toksikol 2012;63:551. doi: 10.2478/10004-1254-63-2012-232110.2478/10004-1254-63-2012-232123334051Search in Google Scholar

14. Marashi SM, Majidi M, Sadeghian M, Ahmadi S, Raji Asadabadi H, Nasri Nasrabadi Z. Is the use of cardioactive steroids appropriate in managing aluminium phosphide poisoning-induced heart failure? Arh Hig Rada Toksikol 2013;64:477-8. doi: 10.2478/10004-1254-64-2013-243910.2478/10004-1254-64-2013-243924084357Search in Google Scholar

15. Hartog CS, Natanson C, Sun J, Klein HG, Reinhart K. Concerns over use of hydroxyethyl starch solutions. BMJ 2014;349:g5981. doi: 10.1136/bmj.g598110.1136/bmj.g5981470771825385352Search in Google Scholar

16. Jonville-Bera AP, Autret-Leca E, Gruel Y. Acquired type I von Willebrand’s disease associated with highly substituted hydroxyethyl starch. N Engl J Med 2001;345:622-3. doi: 10.1056/NEJM20010823345081810.1056/NEJM20010823345081811529231Search in Google Scholar

17. Rioux JP, Lessard M, De Bortoli B, Roy P, Albert M, Verdant C, Madore F, Troyanov S. Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery. Crit Care Med 2009;37:1293-8. doi: 10.1097/CCM.0b013e31819cc1a010.1097/CCM.0b013e31819cc1a019242349Search in Google Scholar

18. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA; CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012;367:1901-11. doi: 10.1056/NEJMoa120975910.1056/NEJMoa120975923075127Search in Google Scholar

19. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J; 6S Trial Group; Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 2012;367:124-34. doi: 10.1056/NEJMoa120424210.1056/NEJMoa120424222738085Search in Google Scholar

20. Guidet B, Martinet O, Boulain T, Philippart F, Poussel JF, Maizel J, Forceville X, Feissel M, Hasselmann M, Heininger A, Van Aken H. Assessment of hemodynamic efficacy and safety of 6% hydroxyethyl starch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 2012;16:R94. doi: 10.1186/ cc1135810.1186/cc11358358064022624531Search in Google Scholar